Please provide your email address to receive an email when new articles are posted on . Patients with lupus skin disease had similar survival rates and flares as those without skin manifestations. Due ...

A targeted antibody that blocks plasmacytoid dendritic cells clears skin in patients with moderate-to-severe cutaneous lupus ...

Lupus is a systemic autoimmune disease that creates inflammation in many parts of your body. It can also affect your skin, causing a rash or other skin changes. Most people with lupus will develop ...

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

With recent attention on noninvasive, dermatologic cosmetic procedures—such as laser resurfacing of scars and collagen fillers—more people, including those with lupus, are inquiring about the ...

Persistent rashes, unexplained skin colour changes, scarring and hair loss may sometimes be clues to lupus, an autoimmune disease that can affect more than the skin. For years, Alexa, 13, was taken to ...

Persistent fatigue, joint pain, recurring fever and unusual skin rashes may sometimes point to lupus, an autoimmune disease ...

The Expert Series: Skin Lupus - Beyond the Butterfly Rash 66% of those with lupus will develop some form of skin disease. In this episode of The Expert Series, Victoria Werth, MD will teach you about ...

Lucille, a 57 years old high school physical education coach, started experiencing a rash on her cheeks and nose. The rash worsened every time she went outside. She had been suffering from joint pain ...

Lupus is a chronic, incurable autoimmune disease. The name “lupus” comes from the Latin word for “wolf,” a reference first made in the 13th century by a physician who thought the facial lesions of the ...

Lupus is an autoimmune disease where the body's immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new study has now shown that the natural active ingredient ...

DARMSTADT, Germany, April 30, 2026--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program ...